CPHI NEWS: Univar announces distribution agreement with Swati Spentose

Published: 25-Oct-2013
Ingredients

For Lidocaine products, including Lidocaine Base and Lidocaine HCI in the US


Global chemical distributor Univar has signed an exclusive distribution agreement with Swati Spentose of India to distribute the firm's Lidocaine products, including Lidocaine Base and Lidocaine HCI in the US and Puerto Rico.

These products are used in a variety of anaesthetic and antiarrhythmic applications and are available in topical, oral, transdermal and injectable forms.

'The combined manufacturing expertise from Swati Spentose and Univar’s marketing and sales capabilities offer customers greater access to these active pharmaceutical ingredients (API),' said Tom Nist, Univar USA Director of Pharmaceutical Ingredients. 'The Lidocaine Base and Lidocaine HCl are excellent additions to Univar’s API portfolio.'

Swati Jajodia, CEO of Swati Spentose, added: 'As part of our ongoing commitment to world class manufacturing, we are focused on partnering with companies across the value chain to provide the most comprehensive service to our customers.

'Univar’s extensive distribution network and commitment to safety, makes it an excellent partner to help us reach more customers with our lidocaine products.'

Swati Spentose has been in the pharmaceutical business for over 43 years, manufacturing three key ingredients: Lidocaine, Meloxicam and Melatonin.

The firm has been manufacturing and selling Lidocaine for over 33 years in more than 60 countries worldwide. It is currently the largest Lidocaine manufacturer and exporter from a single site in the world with a capacity of 360mt/annum.

See more

You may also like

Ingredients

Univar Ireland wins National Safety Award

Read more
For sixth year running

Trending Articles

  1. Causes and solutions for dark spots in tablet manufacturing Natoli Engineering examines the causes and solutions for dark spots that can halt production
  2. Logical Biological expands its raw pharma material development and supply capabilities with new lab The raw material supplier can now better serve in vitro diagnostic (IVD) manufacturers, as it has a significantly larger operational capacity
  3. Small molecules: big market opportunities The rapid rise of biologic drugs in recent years has been accompanied by a market narrative that suggests that innovation and new treatments will be fuelled by breakthroughs in this area, leading to a decline in the small molecule pipeline. This is far from true, notes Kevin Cook, Chief Executive Officer at Sterling Pharma Solutions; both are increasing and small molecule drugs continue to be a mainstay of many drug development portfolios
  4. Shasun Chemicals and Drugs Limited
  5. Olon Spa Olon Group is a global leader in the development and production of active pharmaceutical ingredients (APIs) for CDMO and generic markets, integrating chemical synthesis and biological processes while always embracing the highest international safety, quality, and environmental standards.

Upcoming event

CPhI Middle East

10–12 December 2024 | Conference | Riyadh, Saudi Arabia See all

You may also like

Ingredients

Univar Ireland wins National Safety Award

For sixth year running
Ingredients

Univar to distribute Pharmaline range

Includes more than 20 brands for topical applications and solubilisation
Ingredients

Univar expands agreement with Innophos

Will distribute Eral-Protek and BCS specialist phosphates in Turkey
Ingredients

Univar completes acquisition of Basic Chemical Solutions

Mark Byrne joins Univar as chief operating officer
Ingredients

Univar expands Benelux business

Will acquire Quaron business in the region by January 2011
Ingredients

Private equity firm invests in Univar

CD&R acquires 42.5% ownership interest
Ingredients

Univar API distribution partnership with Gharda Chemicals ‘a success’

Univar is now commercially distributing Gharda\'s APIs across Europe
Subscribe now